Please assess the completion status of the following clinical trial:

Trial Title: Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted Malaria

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 years~* Patient is blood group O+~* Anticipated to be hospitalized for at least 3 consecutive days after initial study transfusion~* Expected to require no more than 2 units of Fresh Whole Blood in the 3 days following randomization~* Agree to return to the hospital for the follow-up visits~* Women of Child Bearing Potential must have a negative pregnancy test within 72 hours before randomization when warranted and must agree to practice a medically acceptable contraception regimen or agree to abstain from heterosexual intercourse during their study participation.~* Patient or legally authorized representative has given written informed consent~Exclusion Criteria:~* Symptoms of clinical malaria (confirmed by microscopy)~* Patient has received antimalarial treatment within 7 days prior to randomization~* Fever (Central body temperature greater than 38.5°C)~* Massive bleeding expected to require more than two Fresh Whole Blood units within 3 days from randomization~* Transfusion(s) of a blood product within 1 month prior to randomization~* Acute or chronic medical disorder that, in the opinion of the investigator, would impair the ability of the patient to receive protocol treatment~* Previous treatment with other pathogen-reduced blood products~* Females who are pregnant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Mirasol (Type: EXPERIMENTAL): Transfusions with Mirasol-treated whole blood
- Control (Type: ACTIVE_COMPARATOR): Transfusions with untreated whole blood

Based on this trial design, predict the completion outcome and termination type (if applicable).